Products

Above you can see the drugs for the treatment of cancer marketed by Mundipharma in Denmark.

Focus on one cancer

Cancer is not one disease, but a collective term for many diseases.

Common to them all is that cell growth and cell division have grown out of control. Mundipharma focuses on the treatment of one cancer type – leukaemia.
Leukaemia – or blood cancer – is caused by changes in the DNA in the stem cells which form blood. The changes stop the blood’s stem cells from forming new normal blood cells. The disease occurs in a number of variations, and each individual disease type displays itself in various different ways.

This site is intended for Danish audiences only.

Depocyte®

Obtain information about Depocyte® here:

Min medicin

Product leaflet

Product summary

 

This site is intended for Danish audiences only.

Levact®

Obtain information about Levact® here:

Min medicin

Product leaflet

Product summary

 

This site is intended for Danish audiences only.

© 2019 Mundipharma A/S

Address

Mundipharma A/S
Frydenlundsvej 30, Building E,
2950 Vedbæk - Denmark

Contact

Phone: +45 45 17 48 00
Fax: +45 45 17 48 29
Monday - Friday at 9.00 - 16.00
mundipharma@mundipharma.dk

About Mundipharma

Mundipharma A/S is a part of an international network of independent associated pharmaceutical companies.

Conditions for the use of Mundipharma.dk